| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1545 | 2009 |
| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 953 | 2017 |
| Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection G Cammarota, L Masucci, G Ianiro, S Bibbo, G Dinoi, G Costamagna, ... Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015 | 616 | 2015 |
| Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review G Cammarota, G Ianiro, A Gasbarrini Journal of clinical gastroenterology 48 (8), 693-702, 2014 | 525 | 2014 |
| Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ... The American journal of gastroenterology 97 (11), 2744-2749, 2002 | 523 | 2002 |
| Association of Virulent Helicobacter pylori Strains With Ischemic Heart Disease V Pasceri, G Cammarota, G Patti, L Cuoco, A Gasbarrini, RL Grillo, ... Circulation 97 (17), 1675-1679, 1998 | 504 | 1998 |
| The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy A Armuzzi, F Cremonini, F Bartolozzi, F Canducci, M Candelli, V Ojetti, ... Alimentary pharmacology & therapeutics 15 (2), 163-169, 2001 | 462 | 2001 |
| A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates F Canducci, A Armuzzi, F Cremonini, G Cammarota, F Bartolozzi, P Pola, ... Alimentary pharmacology & therapeutics 14 (12), 1625-1629, 2000 | 373 | 2000 |
| Management and treatment of lactose malabsorption M Montalto, V Curigliano, L Santoro, M Vastola, G Cammarota, R Manna, ... World journal of gastroenterology: WJG 12 (2), 187, 2006 | 344 | 2006 |
| The role of diet on gut microbiota composition. S Bibbo, G Ianiro, V Giorgio, F Scaldaferri, L Masucci, A Gasbarrini, ... European Review for Medical & Pharmacological Sciences 20 (22), 2016 | 335 | 2016 |
| Probiotics in prevention and treatment of obesity: a critical view N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ... Nutrition & metabolism 13 (1), 1-13, 2016 | 333 | 2016 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 317 | 2019 |
| Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ... Digestion 63 (1), 1-7, 2001 | 297 | 2001 |
| Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ... BioMed research international 2013, 2013 | 269 | 2013 |
| Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth G Nucera, M Gabrielli, A Lupascu, EC Lauritano, A Santoliquido, ... Alimentary pharmacology & therapeutics 21 (11), 1391-1395, 2005 | 268 | 2005 |
| Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial EC Nista, M Candelli, F Cremonini, IA Cazzato, MA Zocco, F Franceschi, ... Alimentary pharmacology & therapeutics 20 (10), 1181-1188, 2004 | 248 | 2004 |
| Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome A Lupascu, M Gabrielli, EC Lauritano, E Scarpellini, A Santoliquido, ... Alimentary pharmacology & therapeutics 22 (11‐12), 1157-1160, 2005 | 243 | 2005 |
| Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection G Cammarota, R Cianci, O Cannizzaro, L Cuoco, G Pirozzi, A Gasbarrini, ... Alimentary pharmacology & therapeutics 14 (10), 1339-1343, 2000 | 240 | 2000 |
| Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial G Addolorato, L Leggio, A Ferrulli, S Cardone, G Bedogni, F Caputo, ... Alcohol and Alcoholism 46 (3), 312-317, 2011 | 216 | 2011 |
| The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy G Cammarota, G Ianiro, R Cianci, S Bibbò, A Gasbarrini, D Currò Pharmacology & therapeutics 149, 191-212, 2015 | 200 | 2015 |
